GGrantIndex
Sort

21,281 grants matching influenza

Laboratory And Pre-clinical Studies Of Parainfluenza Viruses

$1,224,204
Brian Murphy · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Clinical Studies of Vaccines for Pandemic Influenza

$1,224,180
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Structure based design of trimer interface epitope focused universal influenza vaccines

$1,224,163
James E Crowe · Vanderbilt University Medical Center · U01 · FY2021 · AI

The "Dynamics of the immune responses to repeat influenza vaccination exposures" (DRIVE) Study

$1,223,323
Sarah Cobey · University Of Chicago · U01 · FY2022 · AI

NIA AD/ADRD Health Care Systems Research Collaboratory

$1,223,258
Vincent Mor · Brown University · U54 · FY2021 · AG

The "Dynamics of the immune responses to repeat influenza vaccination exposures" (DRIVE) Study

$1,222,811
Sarah Cobey · University Of Chicago · U01 · FY2021 · AI

Wirelessly controlled BSL3 vivarium system for automated microdosing in studies of infectious diseases

$1,222,524
Tuan Q Hoang · Fluid Synchrony, Llc · R44 · FY2022 · OD

Analysis of Host-Pathogen Interactions

$1,222,253
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Innate inflammatory responses during pulmonary infections

$1,222,241
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox

$1,221,981
Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2010 · AI

The connection of innate and adaptive anti-cancer immunity

$1,221,774
John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Developing Teixobactin for Respiratory Infections

$1,221,354
Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2024 · AI

Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine

$1,221,150
Anne Searls De Groot · Epivax, Inc. · R01 · FY2017 · AI

Dynamic regulatory network models of human response to influenza virus

$1,221,095
Ivan Marazzi · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AI

Structure based design of trimer interface epitope focused universal influenza vaccines

$1,221,071
James E Crowe · Vanderbilt University Medical Center · U01 · FY2022 · AI

Probiotics to Enhance Influenza Vaccine Immunogenicity

$1,220,717
Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2011 · AT

INFLUENZA A H1N1 PANDEMIC RESPONSE PLAN

$1,220,673
Siitia Lemusu · American Samoa Government-Department Of Human And Social Services · H75 · FY2009 · TP

Microarrays and Macaque Influenza Model

$1,218,545
Michael G Katze · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · AI

Innate inflammatory responses during pulmonary infections

$1,218,475
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Task 02: Manufacture of Influenza for Human Challenge Clinical Trials

$1,217,730
Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2019 · AI

Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage

$1,216,653
Harold A Chapman · University Of California, San Francisco · U01 · FY2020 · HL

Mechanisms of Effective Humoral Immune Responses to HIV-1

$1,215,514
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Structure based design of trimer interface epitope focused universal influenza vaccines

$1,213,432
James E Crowe · Vanderbilt University Medical Center · U01 · FY2023 · AI

Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels

$1,213,216
Donald Bruce Edwards · Texas Biomedical Research Institute · U19 · FY2019 · AI

Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry

$1,211,915
Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA